Samuel Broder

Insider Reports History

Location
Rockville, MD
Signature
/s/ Mark Ballantyne, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Samuel Broder:

Company Role Class Num Shares Value Price $ Report Date Ownership
Sensei Biotherapeutics, Inc. Director Common Stock 8,932 $7,592 $0.8500 10 Jul 2023 Direct
Sensei Biotherapeutics, Inc. Director Stock Option (Right to Buy) 14,550 10 Jul 2023 Direct
Orion Biotech Opportunities Corp. Director Class B ordinary shares 0 17 May 2023 Direct

Insider Reports Filed by Samuel Broder

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SNSE Sensei Biotherapeutics, Inc. 10 Jul 2023 2 $0 4 Director 12 Jul 2023, 17:00
/report/000121390023041170-broder-samuel-2023-05-17 Orion Biotech Opportunities Corp. 17 May 2023 1 $0 4 Director 18 May 2023, 16:05
SNSE Sensei Biotherapeutics, Inc. 10 Jun 2022 2 $0 4 Director 14 Jun 2022, 16:15
/report/000121390021025888-broder-samuel-2021-05-12 Orion Biotech Opportunities Corp. 12 May 2021 0 $0 3 Director 12 May 2021, 21:54